Company Analysis
Sign in

Enveric Biosciences, Inc. (ENVB)

Nasdaq: ENVB · Pharmaceutical Preparations · Cambridge, MA · filing with the SEC since 1996
Full chart Alerts Compare
Grade3.7
◀ Past 2.7● Present 4.5▶ Future 3.6
2 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

31 patents granted to the 8 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Enveric Biosciences, Inc.’s names, not what it holds today.

Patents granted
31
31 utility, 1976 to Dec 31, 2025
Granted in 2025
7
Against 15 in 2024 and 7 in 2023
Applications published
44
11 of them in 2025
Names they are printed under
8
a subsidiary, a former name, its own name
By yearGrantedApplications published
'05'07'18'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Organic fine chemistry13
Pharmaceuticals10
Biotechnology7
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name8 counted
Enveric Biosciences Canada Inc. a subsidiary
named as the applicant on its applications, in CA
0 granted
34 published
Enveric Biosciences Canada Inc. a subsidiary
CA, as the owner printed on each patent
24 granted
0 published
AKOS BIOSCIENCES, INC. a subsidiary
US, as the owner printed on each patent
5 granted
0 published
Akos Biosciences, Inc a subsidiary
named as the applicant on its applications, in US
0 granted
4 published
Jay Pharma Inc. a subsidiary
named as the applicant on its applications, in CA
0 granted
4 published
Spatializer Audio Laboratories, Inc. a former name
US, as the owner printed on each patent
1 granted
1 published
Enveric Biosciences, Inc. its own name
named as the applicant on its applications, in US
0 granted
1 published
JAY PHARMA INC. a subsidiary
CA, as the owner printed on each patent
1 granted
0 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Dec 9, 202512,492,179Substituted ethylamine fused heterocyclic mescaline derivativesOrganic fine chemistryEnveric Biosciences Canada Inc.
Sep 30, 202512,428,408Fused heterocyclic mescaline derivativesOrganic fine chemistryEnveric Biosciences Canada Inc.
Aug 5, 202512,378,195Aminated psilocybin derivatives and methods of usingBiotechnologyEnveric Biosciences Canada Inc.
Jul 15, 202512,358,885Substituted n-propylamine fused heterocyclic mescaline derivativesOrganic fine chemistryEnveric Biosciences Canada Inc.
Jun 24, 202512,338,231N-heterocycle substituted tryptamine derivatives and methods of usingPharmaceuticalsEnveric Biosciences Canada Inc.
Jan 14, 202512,195,439C1-substituted isopropylamine fused heterocyclic mescaline derivativesOrganic fine chemistryEnveric Biosciences Canada Inc.
Jan 7, 202512,187,679Hydroxylated psilocybin derivatives and methods of usingBiotechnologyEnveric Biosciences Canada Inc.
Nov 12, 202412,138,276Halogenated psilocybin derivatives and methods of usingBiotechnologyEnveric Biosciences Canada Inc.
Nov 5, 202412,133,856Multi-substituent psilocybin derivatives and methods of usingPharmaceuticalsEnveric Biosciences Canada Inc.
Oct 29, 202412,128,058Multi-substituent psilocybin derivatives and methods of usingPharmaceuticalsEnveric Biosciences Canada Inc.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Nov 20, 20252025/0352513SALTS OF C4-CARBOXYLIC ACID- AND C4-CARBONOTHIOATE-SUBSTITUTED TRYPTAMINE DERIVATIVES AND METHODS OF USINGOrganic fine chemistryEnveric Biosciences Canada Inc.
Nov 20, 20252025/0352512C4-SUBSTITUTED TRYPTAMINE DERIVATIVES AND METHODS OF USINGOrganic fine chemistryEnveric Biosciences Canada Inc.
Sep 18, 20252025/0289805N-HETEROCYCLE SUBSTITUTED TRYPTAMINE DERIVATIVES AND METHODS OF USINGPharmaceuticalsEnveric Biosciences Canada Inc.
Jul 3, 20252025/0214934C4-SUBSTITUTED TRYPTAMINE DERIVATIVES AND METHODS OF USINGOrganic fine chemistryEnveric Biosciences Canada Inc.
Jun 26, 20252025/0206701C4-CARBONOTHIOATE-SUBSTITUTED TRYPTAMINE DERIVATIVES AND METHODS OF USINGOrganic fine chemistryEnveric Biosciences Canada Inc.
Jun 26, 20252025/0205197SALTS OF C4-CARBOXYLIC ACID- AND C4-CARBONOTHIOATE-SUBSTITUTED TRYPTAMINE DERIVATIVES AND METHODS OF USINGOrganic fine chemistryEnveric Biosciences Canada Inc.
Jun 19, 20252025/0197351C4-CARBOXYLIC ACID-SUBSTITUTED TRYPTAMINE DERIVATIVES AND METHODS OF USINGOrganic fine chemistryEnveric Biosciences Canada Inc.
Apr 24, 20252025/0129036C1-SUBSTITUTED ISOPROPYLAMINE FUSED HETEROCYCLIC MESCALINE DERIVATIVESOrganic fine chemistryEnveric Biosciences Canada Inc.
Mar 27, 20252025/0100967HYDROXYLATED PSILOCYBIN DERIVATIVES AND METHODS OF USINGBiotechnologyEnveric Biosciences Canada Inc.
Feb 20, 20252025/0057861HALOGENATED PSILOCYBIN DERIVATIVES AND METHODS OF USINGBiotechnologyEnveric Biosciences Canada Inc.
What it applied for, 2024 to 2025: Organic fine chemistry 10 · Biotechnology 4 · Pharmaceuticals 4.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton ENVB · research, not advice